Hero Image

Our leadership team

The leadership team of MSD Switzerland in the field of human health.

The spirit of invention starts with our values

We are proud to play an active role in the success of MSD in Switzerland, for patients, our employees and customers. We believe in creating an inclusive, ethically driven and high performing work environment. We not only invest in employee development but also empower all to collaboratively seek solutions to meet our customer and patient needs. Together we can make a difference, together we are inventing for life!

Meet the team

Dimitri Gitas, Managing Director
Dimitri Gitas

Managing Director

Joanna Keiller, Director Business Unit Vaccines & Primary Care
Joanna Keiller

Director Business Unit Vaccines & Primary Care

Dr. Ulrike Thull, Commercial Lead Mid Europe & Switzerland, Immunology
Dr. Ulrike Thull

Commercial Lead Mid Europe & Switzerland, Immunology

Angela Weber, Director Business Unit Hospital Acute Care
Angela Weber

Director Business Unit Hospital Acute Care

Will Wooding, Director Business Unit Oncology
Will Wooding

Director Business Unit Oncology

Dr. Gila Stump, Director Market Access
Dr. Gila Stump

Director Market Access

Beat Obrist, Director DDA at MSD Switzerland
Beat Obrist

Director DDA Operations

Jean-Blaise Defago, Director Policy & Communications
Jean-Blaise Defago

Director Policy & Communications

Dr. Christoph Brombacher, Manager Compliance & Business Practices
Dr. Christoph Brombacher

Manager Compliance & Business Practices

Dr. Peter Csutora, Director Medical Affairs
Dr. Peter Csutora

Director Medical Affairs

Claudia Stadelmann, Director Regulatory Affairs
Claudia Stadelmann

Director Regulatory Affairs

Klaudia Georgi, Director Clinical Operations
Klaudia Georgi

Director Clinical Operations

Lars Andresen, Director Finance
Lars Andresen

Director Finance

Barbara Vandaele, HR Business Partner Lead
Barbara Vandaele

HR Business Partner Lead

Dr. Pascal Nosetti, Legal & Compliance DACH
Dr. Pascal Nosetti

Legal & Compliance DACH

CH-NON-00389, 10/2023